MF
RVMD icon

Magnetar Financial’s Revolution Medicines RVMD Stock Holding History

Magnetar Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,447
Closed -$458K – 1144
2025
Q2 		$458K Sell
12,447
-20,525
-62% -$789K ﹤0.01% 592
2025
Q1 		$1.17M Buy
32,972
+32,882
+36,536% +$1.33M 0.02% 317
2024
Q4 		$3.94K Buy
+90
New +$4.54K ﹤0.01% 588

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Magnetar Financial's RVMD Position: Q3 2025 in Review

Magnetar Financial sold out of Revolution Medicines (RVMD) in Q3 2025, closing a stake of 12,447 shares — an estimated $458K sold.

Magnetar Financial first reported a position in RVMD in Q4 2024 and held it in 3 quarters. The position peaked at $1.17M in Q1 2025. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Magnetar Financial reported no remaining Revolution Medicines position as of Q3 2025 after selling out during the quarter.
  • Magnetar Financial sold 12,447 Revolution Medicines shares in Q3 2025, an estimated $458K.
  • Magnetar Financial first reported a position in Revolution Medicines in Q4 2024 and held it in 3 quarters.
  • Magnetar Financial's Revolution Medicines position peaked at $1.17M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Magnetar Financial's 13F filing for Q3 2025, filed 13 Nov 2025.